Serum Institute To Launch Novavax Vaccine Shot For Children In Six Months
Adar Poonawalla said that their vaccine will be launched in six months adding that it is under trial and has shown excellent data all the way down to the age group of 3.
AstraZeneca
Covaxin Shows Overall Efficacy Of 77.8% Against Symptomatic COVID-19 Cases
The clinical trials as a part of phase III clinical trials involved nearly 25,800 volunteers spanning 25 hospitals across the country.
How Long Do COVID-19 Vaccines Take To Start Working?
Preliminary data suggests that while two doses of the Pfizer vaccine are 88 percent protective against symptomatic infection with the B.1.617.2 variant, a single dose is only 33 percent effective.
How Effective Are Oxford, Pfizer Vaccines On Variant In India ?
The Serum Institute of India is producing the Oxford/AstraZeneca two-dose vaccine as Covishield. The same is being made available among the adult population in India.
Man Dies After First Shot Of AstraZeneca, His Sister Still Insists People Get Vaccinated
Dr Alison Astles said, “My brother was just extraordinarily unlucky. Despite what has happened to our family, we strongly believe that everyone should go for their first and second doses of the AstraZeneca vaccine.”
Data Suggests No Increased Risk Of Blood Clots From AstraZeneca Vaccine
Norway, Denmark, Iceland and one region of Italy have all also temporarily halted their AstraZeneca immunisation programs while they investigate.
Here’s What Natasha Poonawalla Said On Receiving The First Shot Of Covishield Vaccine
Natasha Poonawalla serves as the director of Poonawalla Science Park in the Netherlands and Villoo Poonawalla Racing and Breeding Pvt Ltd.
